Literature DB >> 21536456

Blood pressure fluctuations in posterior reversible encephalopathy syndrome.

Alejandro A Rabinstein1, Jay Mandrekar, Ryan Merrell, Osman S Kozak, Olayemi Durosaro, Jennifer E Fugate.   

Abstract

BACKGROUND: Posterior reversible encephalopathy syndrome (PRES) can be a consequence of hypertensive crisis and is often associated with rapid fluctuations in blood pressure (BP). However, the role of these BP changes in the pathogenesis of PRES has not been formally studied. Our objective was to analyze the relationship between BP fluctuations and the occurrence of PRES.
METHODS: We identified consecutive patients who developed PRES in the hospital and compared them with randomly selected controls matched for age, gender, and history of hypertension (HTN). Systolic BP (SBP) and diastolic BP (DBP) were collected at 2-hour intervals over a 48-hour window before the onset of PRES symptoms. A profile of changes in the values of SBP, DBP, mean arterial pressure (MAP), and pulse pressure (PP) over the 48-hour window was summarized for each individual by calculating a single number (M value) using the approach by Service et al. Comparisons of these summary numbers between the 2 groups (cases and controls) were made with the Wilcoxon signed rank test because of the smaller sample size and paired nature of the data. All tests were 2-sided, and P < .05 was considered statistically significant.
RESULTS: We analyzed the BP profiles in 25 cases of PRES and 25 controls. The median age of PRES patients was 54 years (range 31-72). Fourteen of them (56%) had a history of HTN. Hypertensive encephalopathy was considered the underlying cause of PRES in 13 patients (52%). At the time of the first symptoms of PRES, the mean SBP was 182 ± 20 mm Hg (range 218-145), DBP 95 ± 16 mm Hg (range 134-62), MAP 124 ± 15 (range 152-93), and PP 87 ± 18 (range 123-46). While BP was higher in PRES cases, the severity of HTN was variable and BP fluctuations were not significantly more common than in controls (P = .38 for SBP, .79 for DBP, .25 for MAP, and .73 for PP, respectively).
CONCLUSIONS: Although acute HTN is frequent in patients with PRES, BP fluctuations do not appear to be more common in hospitalized patients who develop PRES compared with controls matched for age and history of HTN. Other predisposing factors must therefore contribute to the development of PRES.
Copyright © 2012 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21536456     DOI: 10.1016/j.jstrokecerebrovasdis.2011.03.011

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  21 in total

Review 1.  Posterior reversible encephalopathy syndrome during the peripartum period: report of four cases and review of the literature.

Authors:  Hasan Buyukaslan; Ugur Lok; Umut Gulacti; Ozgur Sogut; Halil Kaya; Tahir Gokdemir; Oner Yalin
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Effect of blood pressure on reversible posterior leukoencephalopathy syndrome in pre-eclampsia or eclampsia.

Authors:  Fang Xiaobo; Liang Yanling; Chen Dunjin; He Fang; Chen Jia; Zhong Yuhua; Zhang Weixi
Journal:  Hypertens Res       Date:  2017-11-02       Impact factor: 3.872

3.  Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndrome.

Authors:  Neal S Parikh; Andrew D Schweitzer; Robert J Young; Ashley E Giambrone; John Lyo; Sasan Karimi; Anna Knobel; Ajay Gupta; Babak B Navi
Journal:  J Neurol Sci       Date:  2017-06-29       Impact factor: 3.181

4.  Imaging characteristics associated with clinical outcomes in posterior reversible encephalopathy syndrome.

Authors:  Andrew D Schweitzer; Neal S Parikh; Gulce Askin; Ajay Nemade; John Lyo; Sasan Karimi; Anna Knobel; Babak B Navi; Robert J Young; Ajay Gupta
Journal:  Neuroradiology       Date:  2017-03-13       Impact factor: 2.804

5.  Posterior reversible encephalopathy syndrome with documented hyponatraemia.

Authors:  Puneet Aulakh; Eduard Fatakhov; Christopher Francis Koch; Shikha Kapil
Journal:  BMJ Case Rep       Date:  2013-07-31

6.  Acute hemiparesis and status epilepticus following endoscopic esophageal balloon dilation: is it really a stroke?

Authors:  Nicholas Di Mascio; Padraic MacMathuna; Sean Murphy; Eoin Carl Kavanagh
Journal:  Clin J Gastroenterol       Date:  2018-10-20

Review 7.  Posterior Reversible Encephalopathy Syndrome After Transplantation: a Review.

Authors:  Sheng Chen; Jun Hu; Liang Xu; Dixon Brandon; Jun Yu; Jianmin Zhang
Journal:  Mol Neurobiol       Date:  2015-12-14       Impact factor: 5.590

8.  Spinal cord involvement in two children with posterior reversible encephalopathy syndrome.

Authors:  Maurizio Lucchesi; Mario Mascalchi; Federico Mussa; Claudio Favre; Lorenzo Genitori; Iacopo Sardi
Journal:  CNS Oncol       Date:  2017-10-06

9.  A Case of Synthetic Cannabinoid (K2)-Induced Posterior Reversible Encephalopathy Syndrome (PRES).

Authors:  Haider Ghazanfar; Aruna Muthumanickam; Zaheer Qureshi; Faryal Altaf; Cosmina Zeana; Sridhar Chilimuri
Journal:  Am J Case Rep       Date:  2022-04-26

10.  A Grave Outcome of Posterior Reversible Encephalopathy Syndrome in a Patient Receiving Avastin (Bevacizumab) for Metastatic High-Grade Serous Ovarian Cancer.

Authors:  Hind H Elmalik; Shereen ElAzzazy; Khaled S Salem; Salha Bujassoum
Journal:  Case Rep Oncol       Date:  2015-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.